-
1
-
-
0028258794
-
How many people in the world have multiple sclerosis?
-
Dean G. How many people in the world have multiple sclerosis? Neuroepidemiology 1994 13 : 1.
-
(1994)
Neuroepidemiology
, vol.13
, pp. 1
-
-
Dean, G.1
-
2
-
-
34248365318
-
Combination therapies for multiple sclerosis: Scientific rationale, clinical trials, and clinical practice
-
review).
-
Costello F, Stüve O, Weber MS, Zamvil SS, Frohman E. Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice. Curr Opin Neurol 2007 20 : 281 (review).
-
(2007)
Curr Opin Neurol
, vol.20
, pp. 281
-
-
Costello, F.1
Stüve, O.2
Weber, M.S.3
Zamvil, S.S.4
Frohman, E.5
-
3
-
-
0033544299
-
Multiple sclerosis: Side effects of interferon beta therapy and their management
-
review).
-
Walther EU, Hohfeld R. Multiple sclerosis: side effects of interferon beta therapy and their management. Neurology 1999 53 : 1622 (review).
-
(1999)
Neurology
, vol.53
, pp. 1622
-
-
Walther, E.U.1
Hohfeld, R.2
-
4
-
-
33845208781
-
Panniculitis and lipoatrophy after subcutaneous injection of interferon β-1b in a patient with multiple sclerosis
-
letter).
-
O'Sullivan SS, Cronin EM, Sweeney BJ, Bourke JF, Fitzgibbon J. Panniculitis and lipoatrophy after subcutaneous injection of interferon β-1b in a patient with multiple sclerosis. J Neurol Neurosurg Psychiatry 2006 77 : 1382 (letter).
-
(2006)
J Neurol Neurosurg Psychiatry
, vol.77
, pp. 1382
-
-
O'Sullivan, S.S.1
Cronin, E.M.2
Sweeney, B.J.3
Bourke, J.F.4
Fitzgibbon, J.5
-
5
-
-
0027418515
-
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
-
The IFNB Multiple Sclerosis Study Group.
-
The IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993 43 : 655.
-
(1993)
Neurology
, vol.43
, pp. 655
-
-
-
6
-
-
0032494792
-
Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis
-
European Study Group on interferon β-1b in secondary progressive MS.
-
European Study Group on interferon β-1b in secondary progressive MS. Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis. Lancet 1998 352 : 1491.
-
(1998)
Lancet
, vol.352
, pp. 1491
-
-
-
7
-
-
0029161628
-
Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial
-
The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI analysis group.
-
The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI analysis group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995 45 : 1277.
-
(1995)
Neurology
, vol.45
, pp. 1277
-
-
-
8
-
-
0008376732
-
Interferon beta in the treatment of multiple sclerosis. Mechanisms of action
-
Yong VW, Chabot S, Stuve O, Williams G. Interferon beta in the treatment of multiple sclerosis. Mechanisms of action. Neurology 1998 51 : 682.
-
(1998)
Neurology
, vol.51
, pp. 682
-
-
Yong, V.W.1
Chabot, S.2
Stuve, O.3
Williams, G.4
-
9
-
-
0027946071
-
Neutralizing interferon β antibodies in melanoma patients treated with recombinant and natural interferon β
-
Fierlbeck G, Schreiner T, Schaber B, Walser A, Rassner G. Neutralizing interferon β antibodies in melanoma patients treated with recombinant and natural interferon β. Cancer Immunol Immunother 1994 39 : 263.
-
(1994)
Cancer Immunol Immunother
, vol.39
, pp. 263
-
-
Fierlbeck, G.1
Schreiner, T.2
Schaber, B.3
Walser, A.4
Rassner, G.5
-
10
-
-
0347047191
-
Interferon beta-1b injection site reactions and necroses
-
Gaines AR, Varricchio F. Interferon beta-1b injection site reactions and necroses. Mult Scler 1998 4 : 70.
-
(1998)
Mult Scler
, vol.4
, pp. 70
-
-
Gaines, A.R.1
Varricchio, F.2
-
11
-
-
0030793925
-
Cutaneous reactions to recombinant human interferon beta-1b: The clinical and histologic spectrum
-
Elgart GW, Sheremata W, Ahn YS. Cutaneous reactions to recombinant human interferon beta-1b: the clinical and histologic spectrum. J Am Acad Dermatol 1997 37 : 553.
-
(1997)
J Am Acad Dermatol
, vol.37
, pp. 553
-
-
Elgart, G.W.1
Sheremata, W.2
Ahn, Y.S.3
-
12
-
-
0042624739
-
Necrotizing skin lesions and NABs development in a multiple sclerosis patient treated with IFN β 1b
-
Casoni F, Merelli E, Bedin R, Martella A, Cesinaro A, Bertolotto A. Necrotizing skin lesions and NABs development in a multiple sclerosis patient treated with IFN β 1b. Mult Scler 2003 9 : 420.
-
(2003)
Mult Scler
, vol.9
, pp. 420
-
-
Casoni, F.1
Merelli, E.2
Bedin, R.3
Martella, A.4
Cesinaro, A.5
Bertolotto, A.6
-
13
-
-
0033576097
-
Skin reactions to interferon beta in a series of 92 patients with multiple sclerosis
-
Spanish).
-
Fortuno Y, Marcoval J, Gallego I, Moreno A, Arbizu T, Peyri J. Skin reactions to interferon beta in a series of 92 patients with multiple sclerosis. Med Clin (Barc) 1999 113 : 447 (Spanish).
-
(1999)
Med Clin (Barc)
, vol.113
, pp. 447
-
-
Fortuno, Y.1
Marcoval, J.2
Gallego, I.3
Moreno, A.4
Arbizu, T.5
Peyri, J.6
-
14
-
-
0030994109
-
Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature
-
Weinberg JM, Wolfe JT, Sood S, Saruk M, Rook AH, Spiers EM. Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature. Acta Derm Vernereol 1997 77 : 146.
-
(1997)
Acta Derm Vernereol
, vol.77
, pp. 146
-
-
Weinberg, J.M.1
Wolfe, J.T.2
Sood, S.3
Saruk, M.4
Rook, A.H.5
Spiers, E.M.6
-
15
-
-
0036177776
-
Cutaneous mucinoses complicating interferon beta-1b therapy
-
Benito-León J, Borbujo J, Cortés L. Cutaneous mucinoses complicating interferon beta-1b therapy. Eur Neurol 2002 47 : 123.
-
(2002)
Eur Neurol
, vol.47
, pp. 123
-
-
Benito-León, J.1
Borbujo, J.2
Cortés, L.3
-
16
-
-
23844552827
-
Abdominal wall ulceration and mucinosis secondary to recombinant human interferon- β-1b
-
Wells J, Kossard S, McGrath M. Abdominal wall ulceration and mucinosis secondary to recombinant human interferon- β-1b. Australas J Dermatol 2005 46 : 202.
-
(2005)
Australas J Dermatol
, vol.46
, pp. 202
-
-
Wells, J.1
Kossard, S.2
McGrath, M.3
-
18
-
-
59149105872
-
Interferon beta injection site reaction: A lupus like histology
-
abstract).
-
Ferringer T, Sewell L, Miller O. Interferon beta injection site reaction: a lupus like histology. J Cutan Pathol 2008 35 : 166 (abstract).
-
(2008)
J Cutan Pathol
, vol.35
, pp. 166
-
-
Ferringer, T.1
Sewell, L.2
Miller, O.3
-
19
-
-
0031765912
-
Granulomatous dermatitis with focal sarcoidal features associated with recombinant interferon β-1b injections
-
Mehta CL, Tyler RJ, Cripps DJ. Granulomatous dermatitis with focal sarcoidal features associated with recombinant interferon β-1b injections. J Am Acad Dermatol 1998 39 : 1024.
-
(1998)
J Am Acad Dermatol
, vol.39
, pp. 1024
-
-
Mehta, C.L.1
Tyler, R.J.2
Cripps, D.J.3
-
20
-
-
0036191371
-
Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient
-
Heinzerling L, Drummer R, Burg G, Schmid-Grenelmeier P. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient. Eur J Dermatol 2002 12 : 194.
-
(2002)
Eur J Dermatol
, vol.12
, pp. 194
-
-
Heinzerling, L.1
Drummer, R.2
Burg, G.3
Schmid-Grenelmeier, P.4
-
21
-
-
0031942959
-
Extensive cutaneous-subcutaneous infiltration as a side-effect of interferon beta injection
-
German).
-
Ziegler VR, Kranke B, Soyer P, Aberer W. Extensive cutaneous-subcutaneous infiltration as a side-effect of interferon beta injection. Hautarzt 1998 49 : 310 (German).
-
(1998)
Hautarzt
, vol.49
, pp. 310
-
-
Ziegler, V.R.1
Kranke, B.2
Soyer, P.3
Aberer, W.4
-
22
-
-
33644944164
-
Lipoatrophy: A non-reversible complication of subcutaneous interferon-beta 1a treatment of multiple sclerosis
-
letter).
-
Beiske AG, Myhr KM. Lipoatrophy: a non-reversible complication of subcutaneous interferon-beta 1a treatment of multiple sclerosis. J Neurol 2006 253 : 377 (letter).
-
(2006)
J Neurol
, vol.253
, pp. 377
-
-
Beiske, A.G.1
Myhr, K.M.2
-
23
-
-
84861573415
-
Lobular panniculitis at the site of glatiramer acetate injections for the treatment of relapsing-remitting multiple sclerosis. a report of 2 cases
-
Online early articles]. Available at. accessed 22 November 2007).
-
Ball NJ, Cowan BJ, Moore GRW, Hashimoto SA. Lobular panniculitis at the site of glatiramer acetate injections for the treatment of relapsing-remitting multiple sclerosis. A report of 2 cases. 2007. J Cutan Pathol Online early articles]. Available at http://www.blackwell-synergy.com/toc/up/0/0 (accessed 22 November 2007).
-
(2007)
J Cutan Pathol
-
-
Ball, N.J.1
Cowan, B.J.2
Moore, G.R.W.3
Hashimoto, S.A.4
-
24
-
-
0034798067
-
The neutralization of interferons by antibody
-
Grossberg SE, Kawade Y, Kohase M, Yokoyama H, Finter N. The neutralization of interferons by antibody. J Interferon Cytokine Res 2001 21 : 729.
-
(2001)
J Interferon Cytokine Res
, vol.21
, pp. 729
-
-
Grossberg, S.E.1
Kawade, Y.2
Kohase, M.3
Yokoyama, H.4
Finter, N.5
-
25
-
-
0005489101
-
Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b. Experience during the first three years
-
The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI analysis group.
-
The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI analysis group. Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b. Experience during the first three years. Neurology 1996 47 : 889.
-
(1996)
Neurology
, vol.47
, pp. 889
-
-
-
29
-
-
25844482090
-
Subcutaneous interferon-β injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine induction
-
Buttmann M, Goebeler M, Toksoy A, et al. Subcutaneous interferon-β injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine induction. J Neuroimmunol 2005 168 : 175.
-
(2005)
J Neuroimmunol
, vol.168
, pp. 175
-
-
Buttmann, M.1
Goebeler, M.2
Toksoy, A.3
-
30
-
-
0021265575
-
Studies on safety problem by skin tests using human beta interferon preparation
-
Muranaka M, Suzuki S. Studies on safety problem by skin tests using human beta interferon preparation. J Interferon Res 1984 4 : 115.
-
(1984)
J Interferon Res
, vol.4
, pp. 115
-
-
Muranaka, M.1
Suzuki, S.2
|